| 今开：68.57 | 昨收：68.57 |
| 最高：69.85 | 最低：68.2405 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：1.5405740926E10 |
智通财经APP获悉，当地时间6月13日，美国FDA宣布批准礼来(LLY.US)和因塞特(INCY.US)联合开发的口服JAK抑制剂巴瑞替尼(英文商品名Olumiant)上市，用于治疗严重斑秃成人患者。值得一提的是，这是美国FDA批准用于治疗斑秃的首款系统性疗法... 网页链接
智通财经APP获悉，美国FDA于当地时间7月29日扩大了礼来(LLY.US)与因塞特医疗(INCY.US)的baricitinib药物(商用名Olumiant)的紧急适用授权(EUA)。根据修订后的EUA，治疗确诊新冠的住院患者时，baricitinib不需与吉利德科学(GILD.US)的Vekl... 网页链接
$因塞特医疗(INCY)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000879169-24-000095 Size: 7 KB 网页链接
$因塞特医疗(INCY)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000879169-24-000097 Size: 7 KB 网页链接
$因塞特医疗(INCY)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000879169-24-000094 Size: 7 KB 网页链接
$因塞特医疗(INCY)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000879169-24-000098 Size: 5 KB 网页链接
$因塞特医疗(INCY)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000879169-24-000091 Size: 7 KB 网页链接
$因塞特医疗(INCY)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000879169-24-000092 Size: 7 KB 网页链接
$因塞特医疗(INCY)$ 8-K Current report, items 5.07 and 9.01 Accession Number: 0000879169-24-000082 Act: 34 Size: 167 KB 网页链接
$因塞特医疗(INCY)$ SC TO-I/A [Amend] Tender offer statement by Issuer Accession Number: 0001104659-24-071072 Act: 34 Size: 64 KB 网页链接
$因塞特医疗(INCY)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-004696 Act: 33 Size: 15 KB 网页链接
$因塞特医疗(INCY)$ SC TO-I/A [Amend] Tender offer statement by Issuer Accession Number: 0001104659-24-070209 Act: 34 Size: 39 KB 网页链接